(The Lancet) Results from a randomised controlled trial involving 300 prostate cancer patients find that a molecular imaging technique is more accurate than conventional medical imaging and recommends the scans be introduced into routine clinical practice.

Original source: https://www.eurekalert.org/pub_releases/2020-03/tl-pss031820.php